AEGR

Aegerion Pharmaceuticals
AEGR

Delisted

AEGR was delisted on the 29th of November, 2016.

95 hedge funds and large institutions have $721M invested in Aegerion Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$23.1M
Puts
$46M
Net Calls
Net Calls Change

Top Buyers

1 +$32.3M
2 +$27.8M
3 +$23M
4
Goldman Sachs
Goldman Sachs
New York
+$12.3M
5
SCM
Scopia Capital Management
New York
+$6.83M

Top Sellers

1 -$29.2M
2 -$29.2M
3 -$22.9M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.8M
5
HM
HealthCor Management
New York
-$15.5M
Name Holding Trade Value Shares
Change
Change in
Stake
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125